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Background: By using a noncontact mapping system, adenosine triphosphate (ATP)-sensitive atrial
tachycardia (ATP-AT) originating from the atrioventricular (AV) node vicinity was successfully ablated at
the entrance to the slow conduction zone indicated by the manifest entrainment technique. We aimed to
prospectively validate the efﬁcacy of the combination of CARTO electroanatomical mapping and manifest
entrainment in ablating this ATP-AT.
Methods: Of the 27 AT patients from January 2013 to March 2014, 6 patients with sustained ATP-AT were
studied (age, 67713 years; tachycardia cycle length, 350795 ms). We ﬁrst created the CARTO map
during AT, and performed rapid pacing from the anterior right atrial wall (ARAW) and cavotricuspid
isthmus (CTI) approximately 30 mm remote from the earliest activation site (EAS). We identiﬁed the site
where manifest entrainment, deﬁned as the orthodromic capture of the EAS with a long conduction time,
was observed, and ablated the site approximately 20 mm remote from the EAS, between the pacing site
and the EAS.
Results: Manifest entrainment was demonstrated in all patients paced from the ARAW (four patients)
and from the CTI (two patients). Ablation at the prespeciﬁed site terminated AT in 673 s, and AT became
no longer inducible in all patients. At the successful ablation sites, discrete atrial electrograms were
recorded; however, low-amplitude, fractionated electrograms suggestive of slow conduction were not
observed in all patients. The atrio-His interval during sinus rhythm remained unchanged (from 96712
to 8977 ms, p¼NS). During 1176 months, no patients showed AT recurrence and AV conduction
abnormality.
Conclusion: CARTO mapping- and manifest entrainment-guided ablation strategy is effective and safe in
the treatment of ATP-AT.
& 2015 Japanese Heart Rhythm Society. Published by Elsevier B.V. This is an open access article under the
CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Entrainment pacing is useful not only in establishing reentry as
a mechanism of tachycardia but also in identifying the pacing site
relative to the slow conduction zone [1–3]. When manifest
entrainment represented by constant fusion except for the last
entrained beat in the electrocardiogram (ECG) is demonstrated,blished by Elsevier B.V. This is an
irosaki University Graduate
Japan. Tel.: þ81 172 39 5056;
kumura).the pacing site is proximal to the slow conduction zone. When
entrainment showing concealed fusion in the ECG, postpacing
interval equal to the tachycardia cycle length and stimulus-to-QRS
(P) equal to electrogram-to-QRS (P), is demonstrated, the pacing
site is on the critical slow conduction zone [4–6]. This “concealed
entrainment” is widely used as a tool to identify the effective
ablation site in reentrant tachycardias.
Adenosine- or adenosine triphosphate (ATP)-sensitive atrial
tachycardia (AT) (ATP-AT) with the earliest activation site (EAS) in
the atrioventricular (AV) node vicinity was reported to be due to
reentry [7], and catheter ablation performed for this speciﬁc AT
has targeted the EAS with some risk of AV conduction impairment.open access article under the CC BY-NC-ND license
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AV node but also in other sites, including the coronary sinus
ostium [8,9], tricuspid annulus [10,11], mitral annulus [12], and
others [13]. By applying a single extrastimulus during ATP-AT
originating from the AV node vicinity, Yamabe et al. demonstrated
that verapamil- or ATP-sensitive atrial tissue not in the AV con-
duction system but close to the AV node forms the tachycardia
reentry circuit [9]. More recently, while localizing the pacing site
relative to the EAS during ATP-AT by using a noncontact mapping
system (EnSite), Yamabe et al. demonstrated that this AT could be
entrained by rapid pacing at a site remote from the EAS, fulﬁlling
the classic or manifest entrainment criteria, and successfully
ablated at the site that is supposed to be the entrance to the slow
conduction zone [14]. This entrainment-based approach is rather
different from those used previously [7–13], and therefore needs
to be further validated. In the present study, we aimed to pro-
spectively validate the efﬁcacy of the combined use of a contact
electroanatomical mapping system (CARTO) that is more accurate
than the EnSite noncontact mapping system, and manifest
entrainment in ablating this ATP-AT. We also sought whether any
abnormal low-amplitude and fractionated electrograms, sugges-
tive of slow conduction allowing small circuit reentry [15,16], were
present particularly at the successful ablation site.2. Material and methods
2.1. Study patients
Of the consecutive 27 patients with right AT, not including
typical or atypical AV nodal reentrant tachycardia (AVNRT), and
undergoing catheter ablation from January 2013 to March 2014, 7
(26%) had a diagnosis of ATP-AT with the EAS in the vicinity of the
AV node. In one patient, AT was terminated during catheter
mapping and sustained AT was no longer inducible. This study
therefore included the successive six patients with sustained ATP-
AT showing stable tachycardia cycle length, with variation
o15 ms. The patients comprised two men and four women, with a
mean age of 67713 years (range, 55–83 years). Structural heart
disease (dilated cardiomyopathy) was present in one patient.
In all study patients, a small dose of ATP (5 mg) terminated the
tachycardia. AVNRT was excluded according to the following cri-
teria [14]: (i) tachycardia induction was independent of the critical
atrio-His (AH) interval prolongation; (ii) induction and perpetua-
tion of tachycardia was independent of AV block; (iii) ventricular
pacing delivered during tachycardia demonstrated AV dissociation
without affecting the tachycardia cycle length; (iv) the His bundle
(HB) electrogramwas advanced by 15 ms by the ventricular pacing
during tachycardia, with no change in the tachycardia cycle length;
(v) spontaneous change in the HA interval with a ﬁxed subsequent
AA interval was observed; (vi) the difference between the AH
interval during atrial pacing and that during tachycardia was
o20 ms; and (vii) a V-A-A-V sequence was observed when
tachycardia was induced by premature ventricular stimulation.
2.2. Cardiac catheterization
The study protocol was in agreement with the guidelines for
clinical studies delineated by the ethics committee of our institution.
All patients gave written informed consent to participate in the
electrophysiological study and catheter ablation. The study was done
in the postabsorptive, nonsedated state. All antiarrhythmic drugs
were discontinued for at least ﬁve half-lives before the procedure.
In all patients, a 7F 4-mm tip mapping catheter with an electrode
spacing of 1–7–4 mm (Navistar; Biosense Webster, Diamond Bar, CA,
USA) and a 5F quadripolar catheter (5–5–5mm interelectrodespacing) (Inquiry catheter; St. Jude Medical, St. Paul, MN, USA) were
introduced through the femoral vein and placed in the right atrium
(RA) for mapping and at the HB region, respectively. The Navistar
catheter was also used for programmed atrial stimulation from the
high RA for the electrophysiologic study. A 5F decapolar catheter (Fe-
po; Fukuda Denshi Co., Ltd., Tokyo, Japan) was introduced through the
internal jugular vein and inserted into the coronary sinus. A 7F
steerable duodecapolar Halo catheter (Inquiry catheter, St. Jude
Medical) was introduced through the femoral vein and positioned
along the tricuspid annulus. All of the electrograms were recorded by
using a digital multichannel system (ComboLab; GE Healthcare,
Waukesha, WI, USA) along with the 12-lead ECG.
AT was induced by programmed atrial stimulation with the use
of a cardiac stimulator (BC-1100, Fukuda Denshi Co., Ltd.). When
sustained AT could not be induced, intravenous isoproterenol (0.5–
1.0 μg/min) was continuously administered. In all study patients,
electroanatomical CARTO mapping of the RA was performed dur-
ing AT with the use of CARTO 3 system (Biosense-Webster, Dia-
mond Bar, CA, USA).2.3. Entrainment and ablation strategy1. While referring to the RA activation map during AT, entrain-
ment pacing was done during sustained AT for about 5 s at a
rate 5–10 beats/min faster than the AT rate from the sites about
30 mm away from the EAS, including the anterior right atrial
wall (ARAW), upper and lower interatrial septum, and cavo-
tricuspid isthmus close to coronary sinus ostium (CTI-CS). For
every attempt of entrainment pacing, we examined whether all
of the atrial electrograms were captured at the pacing cycle
length. If not, entrainment pacing was resumed while increas-
ing the pacing rate by 5 beats/min.
2. Among the entrainment attempts from the four pacing sites, we
identiﬁed the site at which pacing demonstrated manifest
entrainment; manifest entrainment was deﬁned by the ortho-
dromic capture of the electrogram at the EAS with a long con-
duction time by the immediately previous pacing impulse
(N1), and the antidromic capture of the other sites by the
immediate impulse (N) in one paced beat except for the last
entrained beat, equivalent to ﬁrst entrainment criterion.
3. We then applied radiofrequency (RF) energy (20 W) at the site
15–20 mm remote from the EAS between the site showing
manifest entrainment and the EAS. When AT was not termi-
nated, the ablation site was moved by 2 mm laterally or toward
the EAS, and RF energy was applied.
4. The end points of ablation was the termination of AT and the
noninducibility of AT after isoproterenol infusion.2.4. Characteristics of electrograms at the successful ablation site
Most of the reentrant circuits except for typical atrial ﬂutter
have a slow conduction zone, which is often represented by low-
voltage, fractionated electrograms [15,16]. We therefore examined
whether such abnormal electrograms were present at the suc-
cessful ablation site.2.5. Statistical analysis
Continuous variables are expressed as mean71 standard
deviation. Comparison of the AH intervals before and after abla-
tion was done by using a two-tailed paired t test. A p-value of
o0.05 was considered statistically signiﬁcant.
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The baseline characteristics of the study patients are shown in
Table 1. The tachycardia cycle length was 350795 ms. To make the
tachycardia sustained and stable, isoproterenol was infused in four
patients. The activation map during AT was created by sampling from
152728 RA points, and it revealed a focal activation pattern with the
EAS close to the HB recording site in all patients (Fig. 1A). The EAS
during AT was 1177 mm above (n¼3), below (n¼1), posterior
(n¼1), or right (n¼1) to the HB recording site. Four of the six patients
had the EAS within 10 mm from the HB site.
3.1. Entrainment study
Manifest entrainment was demonstrated in all patients by the
pacing from the ARAW in four patients and from the CTI-CS in the
other two patients. The distance between the HB recording and pacing*
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Fig. 1. Panel A, activation map during tachycardia (patient 1), showing a focal activatio
recording site. Panel B, entrainment of tachycardia from the anterior right atrial wall (pati
pacing stimulus. See text for discussion. MAP d and MAP p¼distal and proximal pair of m
the HB recording catheter electrodes, respectively; Halo¼each pair of Halo catheter ele
area; LAO¼ left anterior oblique projection.sites was 2574mm (Table 1). In the two patients with the EAS close
to the HB recording site and with manifest entrainment demonstrated
from the CTI-CS, the V-A and AV intervals in the HB electrogram during
the tachycardiawere 145 and 150ms, respectively, in patient 2, and 115
and 153ms, respectively, in patient 3, indicating that common AVNRT
was unlikely [17]. In all patients, the postpacing interval (PPI) was
longer by Z20ms than the tachycardia cycle length, suggesting that
the pacing site was outside of the reentry circuit.
Fig. 1 shows an example of entrainment of ATP-AT (cycle
length, 420 ms) from the ARAW (pacing cycle length, 400 ms)
(patient 1). The EAS (red tag) was 8 mm above the HB recording
site (yellow tag), and the pacing site (blue tag) was 32 ms away
from the EAS (panel A). Among the atrial electrograms recorded
(panel B), that at the HB recording site was the earliest. The red
and blue asterisks indicate the last electrograms captured by the
last pacing stimulus. It was noted that the atrial electrograms at
the HB recording site and recorded in Halo 1/2 to 5/6, and the500 msec
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apping catheter electrodes, respectively; HB d and HB p¼distal and proximal pair of
ctrodes; CS¼each pair of coronary sinus catheter electrodes; TVA¼tricuspid valve
Table 1
Baseline characteristics and entrainment study.
Pt no. Age/sex AT CL (ms) ISP dose (μg/min) EAS Manifest entrainment
7 Site Distance from the HB (mm)
1 57/F 420 – 8 mm above the HB þ ARAW 32
2 55/F 295 0.5 6 mm below the HB þ CTI-CS 25
3 55/M 268 1.0 12 mm above the HB þ CTI-CS 26
4 83/F 511 0.5 9 mm posterior to the HB þ ARAW 21
5 80/M 296 1.0 8 mm above the HB þ ARAW 25
6 70/F 312 – 20 mm right to the HB þ ARAW 37
Mean7SD 67713 350795 1177 mm from the HB 2574
ARAW¼anterior right atrial wall; AT CL¼atrial tachycardia cycle length; CTI-CS¼cavotricuspid isthmus close to coronary sinus ostium; EAS¼earliest activation site;
F¼female; HB¼His bundle recording site; ISP¼ isoproterenol; M¼male; Pt¼patient; SD¼standard deviation.
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Fig. 2. Entrainment from a site in the cavotricuspid isthmus close to the coronary sinus ostium in the same case as in Fig. 1. Blue asterisks indicate the last electrograms
captured by the last pacing stimulus. See text for discussion. All abbreviations are as in Fig. 1.
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Fig. 3. Location of the earliest activation site (EAS), manifest entrainment site, and
successful ablation site relative to the His bundle (HB) recording site for all six
patients. CSos¼coronary sinus ostium; TVA¼tricuspid valve area.
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a long conduction interval (red arrows) and with the same
morphologies as during the tachycardia. The other electrograms
(blue asterisks) were captured directly or antidromically, showing
different morphologies from those during the tachycardia. Thus,
manifest entrainment was demonstrated, indicating that this
pacing site (ARAW) was proximal to the slow conduction zone.
Fig. 2 shows entrainment pacing from the CTI-CS in the same
case as in Fig. 1, and all of the atrial electrograms were captured
directly or antidromically (blue asterisks), showing different
morphologies from those during the tachycardia. This indicates
that the pacing site was distal to the slow conduction zone.
3.2. Catheter ablation
RF energy was applied during AT in all patients, except in one in
whom it was during sinus rhythm because AT became unsustained
after the entrainment study. Fig. 3 illustrates the location of the EAS,
manifest entrainment site, and successful ablation site relative to the
HB recording site for all six patients. In four patients, the ablation site
A H V A VH
A
V
V A V
A
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Fig. 4. Panel A, successful ablation site in the left lateral view (patient 1). It is located between the manifest entrainment pacing site and the His bundle (HB) recording site,
and 15 mm from the HB site toward the pacing site. Panel B, ﬂuoroscopy images showing the relative location of the ablation catheter (ABL) to the other catheters at the HB
recording site, coronary sinus (CS), and Halo catheter in the right atrium. Panel C, termination of tachycardia after the application of radiofrequency (RF) energy. RAO¼right
anterior oblique projection; LAO¼ left anterior oblique projection. All other abbreviations are as in Fig. 1.
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it was close to the coronary sinus ostium.
Fig. 4A shows the ablation site in patient 1, which was between
the ARAW showing manifest entrainment and the HB recording
site, and 15 mm from the HB site toward the pacing site. The
ﬂuoroscopy image shows the ablation site remote from the HB
recording site (Fig. 4B). The application of RF energy at this site
resulted in the termination of tachycardia at 8 s after the initiation
of ablation (Fig. 4C). A total of four RF applications resulted in the
elimination of AT even after isoproterenol infusion.
A similar observation was made in the other four patients in
whom ablation was done during AT, and AT was terminated in
673 s (range, 3–11 s) after the RF application. Table 2 summarizesthe results of ablation. AT was terminated or became noninducible
by 1–3 RF applications, and the total application number was
3.7 per patient (range, 2–6). AT became no longer inducible even
after isoproterenol infusion in all patients. The distance between
the successful ablation site and the HB site was 1972 mm. The AH
interval was 96712 ms before and 8977 ms after ablation
(p¼0.13). In two of the patients, acceleration of tachycardia or
cycle length irregularity was noted before the termination of
tachycardia. Junctional rhythm or tachycardia was noted during
ablation in none of the patients.
During a mean follow-up period of 1176 months (range, 5–19
months), no patients experienced recurrence of the tachycardia. There
were no adverse events, including AV conduction disturbance.
Table 2
Results of ablation.
Ablation AH interval (ms)
Pt no. Ablation site Distance from the HB
(mm)
No. of successful ablation (total
application)
Acceleration during RF Before ablation After ablation
1 1 O'clock 15 During AT 1 (4) þ 104 92
2 3 O'clock 20 During AT 1 (2)  96 80
3 5 O'clock 20 During sinus 1 (2) 102 97
4 1 O'clock 18 During AT 3 (4) þ 110 98
5 1 O'clock 18 During AT 1 (4)  87 85
6 0 O'clock 20 During AT 3 (6)  76 84
Mean7SD 1972 96712 8977
AH¼atrio-His; AT¼atrial tachycardia; HB¼His bundle recording site; Pt no.¼patient number; RF¼radiofrequency.
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Fig. 5. Bipolar atrial electrograms (MAP) recorded at the three sites illustrated in Fig. 4A (numbers in the circle). Arrows indicate atrial electrograms. Ref¼reference electrogram.
Fig. 6. Panel A, another example showing a focal pattern of activation during the tachycardia (patient 2). Panel B, bipolar atrial electrograms (MAP) recorded at the three sites
illustrated in panel A (circled numbers). Arrows indicate atrial electrograms. EAS¼earliest activation site; HB¼His bundle recording site; Ref¼reference electrogram;
TVA¼tricuspid valve area; LAO¼ left anterior oblique projection.
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Fig. 5 shows the bipolar atrial electrograms (MAP) recorded at the
three sites illustrated in Fig. 4A (numbers in the circle). As indicated
by arrows, no abnormal, fractionated electrograms were found. Fig. 6
shows another example with the manifest entrainment pacing site in
the CTI-CS and the successful ablation site close to the coronary sinusostium (patient 2). The atrial electrograms recorded at three sites
(circled numbers in panel A) all showed normal conﬁguration, and no
fractionated potentials were noted (panel B). The other patients also
had no abnormal electrograms at the successful ablation site and at
the sites between the ablation site and the HB site or the EAS. The
mean amplitude of the bipolar atrial electrogram at the successful
ablation site was 0.870.3 mV (range, 0.3–1.0 mV), and the ratio of
K. Okumura et al. / Journal of Arrhythmia 32 (2016) 133–140 139the atrial to the ventricular electrogram was 1.270.9 (range, 0.3–2.3)
for all patients.4. Discussion
4.1. Major ﬁndings
With the use of CARTO mapping- and manifest entrainment-
guided ablation strategy, ATP-AT originating from the AV node
vicinity could be eliminated effectively and safely without causing
AV conduction disturbance. We again demonstrated reentry with a
slow conduction zone as a mechanism of tachycardia [7]; however,
we failed to record any abnormal low-amplitude or fraction-
ated potentials at the successful ablation sites. Although the
mechanism for slow conduction remains unexplained, this study
validated the ablation strategy in which RF application is targeted
for the site remote from the EAS. This ablation strategy can be used
as a ﬁrst-line approach to ATP-AT originating from the AV node
vicinity.
4.2. Mechanism of ATP-AT originating from the AV node vicinity
Iesaka et al. ﬁrst reported AT mimicking the atypical form of AV
nodal reentrant tachycardia and sensitive to a small dose of ATP
[7], and suggested focal reentry without involvement of the AV
nodal pathways. Yamabe et al. recently demonstrated that ver-
apamil- or ATP-sensitive atrial tissue not in the AV conduction
system forms the tachycardia reentry circuit of this AT [9]. Fur-
thermore, by using a noncontact mapping system, it was demon-
strated that this AT can be entrained by pacing at a site remote
from the EAS, fulﬁlling the classic entrainment criteria [14]. This
article ﬁrst revealed the spatial relation of the ablation site and
EAS, but did not demonstrate any direct evidence of a slow con-
duction zone. Thus, the anatomical localization of the reentry
circuit of this AT still remains to be determined.
With the use of a more accurate contact mapping system
(CARTO), we showed a focal activation pattern during ATP-AT in
the successive six patients. As demonstrated previously [14], AT
was entrained by the pacing from the ARAW or CTI-CS, fulﬁlling
the present criteria for manifest entrainment. To demonstrate
manifest entrainment, we carefully chose the pacing site from
among the ARAW, upper and lower interatrial septum, and CTI-CS.
Moreover, the pacing rate was set to be faster by only 5–10 beats/
min than the AT rate, which resulted in the increase of the AT rate
to the pacing rate. Accordingly, we demonstrated manifest
entrainment from one site in all patients. Pacing at faster rates
would result in the antidromic capture of the EAS such as that
seen during pacing from a site distal to a slow conduction zone
(Fig. 2).
Most important, we again demonstrated a long conduction
interval during entrainment. As this AT could be eliminated by a
few RF applications between the manifest entrainment pacing site
and the EAS, the presence of a slow conduction zone is strongly
suggested at least in this area. We therefore concentrated on
ﬁnding any abnormal, low-amplitude, fractionated electrograms
that allow slow conduction and small reentry mimicking focal
tachycardia [16]. As shown in Figs. 5 and 6, however, we failed to
record such abnormal potentials. Thus, the mechanism of this AT
can be explained by reentry functionally, but still not anatomically
even with a contact mapping system.
In the AV nodal reentrant tachycardia, the slow pathway serves
as a slow conduction zone. However, there have been no reports
demonstrating evidence for slow pathway activation during the
tachycardia by using a conventional catheter electrode technique
[18]. Even with the current technologies, recording potentials fromthe tissues with Ca channel-dependent conduction such as the AV
node is not possible in the human heart. It should be remembered
that AV node-like structures are present along the tricuspid
annulus of the normal hearts as remnants of specialized AV ring
tissue [19]. There are cells with AV nodal characteristics present in
the superﬁcial layer of the tricuspid annulus of porcine and canine
hearts [20]. In fact, AT originating from the tricuspid annulus other
than the AV node vicinity and with similar properties to the pre-
sent ATP-AT has been reported [8,9,13]. In the present six patients,
manifest entrainment was possible only from the ARAW (Fig. 1A)
and CTI-CS (Fig. 6A), both of which were close to the tricuspid
annulus, and the mean ratio of the atrial to the ventricular elec-
trograms at the successful ablation site was 1.2. Thus, the AV node-
like or transitional cell tissue is suggested to be present over the
normal atrial myocardium in the tricuspid annulus, and serves as a
slow conduction zone in the present ATP-AT. The acceleration of
tachycardia during RF application seen in two patients also sug-
gests the presence of AV node-like tissue. A technical inability to
show slowly conducting impulse in this slow conduction zone
possibly resulted in the focal activation pattern in the CARTO map.
4.3. Efﬁcacy and safety of the present ablation strategy
A previous ablation strategy for ATP-AT originating from the AV
node vicinity targeted the EAS during the tachycardia with a risk of
AV conduction impairment. In fact, transient AV block was induced by
this strategy [7]. Yamabe’s strategy and ours target not the EAS but
the site 1972 mm remote from the HB recording site (Fig. 4A, B).
None of the patients showed AV conduction impairment due to the
ablation, and the AH interval remained unchanged. After the ablation,
AT was eliminated in all patients, and during the 11-month period, no
patients experienced a recurrence of AT. Thus, the present manifest
entrainment-guided ablation strategy is effective and safe.
Recently, Yamabe et al. found that verapamil- and ATP-sensitive
AT originating from the tricuspid annulus other than the AV node
vicinity can also be ablated at the site 10.4 mm remote from the
EAS [21]. This AT and the present ATP-AT may form a single entity
of AT with a slow conduction zone in the tricuspid annulus, as
described above.4.4. Limitations
To demonstrate manifest entrainment of AT, a stable, sustained
tachycardia needs to be induced, and therefore, the present abla-
tion strategy cannot be applied to unsustained or unstable tachy-
cardia showing cycle length variation. Isoproterenol seems to be
useful in stabilizing the tachycardia. The number of the study
patients was small. We studied consecutive cases with sustained
ATP-AT in which CARTO mapping and entrainment study was
accomplished. The results were consistent among the cases and,
therefore, the present results may be generalized. Manifest
entrainment can show the relative location of the pacing site to a
slow conduction zone, but cannot directly guide to the successful
ablation site as concealed entrainment can. In fact, for eliminating
AT, a mean of 3.7 RF applications were required. As there were no
speciﬁc electrogram morphologies at the successful ablation,
multiple RF applications may be necessary in some patients. We
sought a site from which manifest entrainment was demonstrated
in this study. If a site with manifest entrainment and with PPI close
to the AT cycle length could be found, then the pacing site should
be close to the entrance to the slow conduction zone. This might
be associated with a reduced number of ablation for eliminating
ATP-AT. Further studies are required.
K. Okumura et al. / Journal of Arrhythmia 32 (2016) 133–1401405. Conclusions
ATP-AT with the EAS in the vicinity of the AV node is due to
reentry with a slow conduction zone not demonstrable either by
the conventional electrode catheter technique or by the CARTO
system. Manifest entrainment-guided ablation strategy is effective
and safe in the treatment of this ATP-AT.Funding sources
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